Relapse rates were not significantly different between Rag1-/- and C57BL/6 mice (Figure A in S1 File), suggesting neither B nor T cells play a major role in the anti-tumour efficiency of ingenol mebutate in the B16 model. The gene discussed is RAG1; the disease is neoplasm.